[monkeyshine]

You’d have to look up those trial numbers at clinicaltrials.gov to see what they are about.

Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals
https://clinicaltrials.gov/ct2/show/NCT04368728?term=04368728&draw=2&rank=1

A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy and Immunocompromised Adults
https://clinicaltrials.gov/ct2/show/NCT04380701?term=04380701&draw=2&rank=1

[week 71]

@ 125 Hello monkeyshine. I cannot be sure if you are a ‘poser’ or not, but truly appreciate your input in the conversation and would contend your freeper voice on this thread is one to consider. Could you be kind enough to interpret briefly those links for laymen? I am familiar with abstracts and sundry scientific papers, but having a hard time with those.

[ransomnote]

You’d have to look up those trial numbers at clinicaltrials.gov to see what they are about.

Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals
https://clinicaltrials.gov/ct2/show/NCT04368728?term=04368728&draw=2&rank=1

A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy and Immunocompromised Adults
https://clinicaltrials.gov/ct2/show/NCT04380701?term=04380701&draw=2&rank=1
~~~~~~~~~
Yes, I did. I find that they combine phase numbers so a section I’m reading will say it’s for phase II/III etc. Sometimes they refer to phase I/II or I/II/III but phase III isn’t complete.